Contrast agent for optical imaging, use thereof and apparatus using the same
Abstract
Provided are a contrast agent for optical imaging, a use thereof and an apparatus using the same. The contrast agent for optical imaging of the present disclosure allows optical imaging without requiring a fluorophore or a luminophore. As a result, the optical images can be acquired without changing the physicochemical properties of a substrate. The contrast agent for optical imaging of the present disclosure may be used as an optical/nuclear bimodal imaging contrast agent for many applications, and allows radiation therapy as well as monitoring of a therapeutic effect thereof through optical imaging at the same time. Further, when a fluorophore is attached thereto, light emission may be enhanced without energy input from outside since light is emitted from the fluorophore, thereby increasing luminescence intensity and improving tissue penetration.
Claims
exact text as granted — not AI-modified1 . A radionuclide detection apparatus for detecting the radionuclide according to claim 1 labeled at a subject existing in a fluid flowing in a tube, comprising: a chamber through which the tube penetrates; a conversion means provided in the chamber and converting the energy of a charged particle emitted from the radionuclide into light; and a light detection means detecting the light converted by the conversion means.
2 . The radionuclide detection apparatus according to claim 1 , wherein the tube penetrating the chamber has a light transmitting portion.Join the waitlist — get patent alerts
Track US2015316658A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.